Gene Therapy Technology for Hemophilia B to Be Created in Sochi

The development will reduce the cost of treatment

The Sirius University of Science and Technology will develop a gene therapy technology for hemophilia B. This was reported by the university's press service.

The development will form the basis for creating new drugs for the therapy of hereditary diseases.

Scientists have chosen hemophilia B as a model disease. New treatment strategies will significantly reduce the cost of treatment and prolong and improve the quality of life for patients.
Press Service of the Sirius University of Science and Technology

Scientists plan to change the approach to treating hemophilia B. Instead of viral vectors, it was decided to use liposomal nanoparticles. They will contain genetic elements and a DNA editing system based on prime editing and base editing technologies.

They allow for the safe correction of genetic information and ensure a long-term therapeutic effect. Such an editing system is capable of making pinpoint, targeted edits of only one nucleotide in size.
Press Service of the Sirius University of Science and Technology

It is worth noting that specialists from the Sirius University previously developed a new method for diagnosing age-related and oncological diseases by measuring vitamin B12 in human cells.

Read more on the topic:

A virtual human cell was developed in Sirius

An effective drug to fight cancer has been developed in Nizhny Novgorod

Rosatom has developed a new technology for producing a drug to treat cancer

Now on home